Idiopathic Intracranial Hypertension Clinical Trial
Official title:
The Relationship Between Intracranial Pressure and Aqueous Outflow in Idiopathic Intracranial Hypertension
NCT number | NCT06436820 |
Other study ID # | 310393. |
Secondary ID | |
Status | Not yet recruiting |
Phase | |
First received | |
Last updated | |
Start date | June 2024 |
Est. completion date | November 2025 |
This study aims to investigate the relationship between intracranial pressure (ICP) and aqueous outflow (the flow of the eye's internal fluid out of the eye), in patients with increased intracranial pressure (idiopathic intracranial hypertension (IIH)). Through observing changes in aqueous outflow facility in patients scheduled for lumbar Puncture (LP) as part of their routine care the objectives we aim to answer include: - Investigating the effect of lumbar puncture induced reduction in ICP on patients with known or suspected IIH, compared to control patients, who will be receiving LP for reasons not pertaining to high pressure. - Comparing pre lumbar puncture aqueous outflow facility between patients with idiopathic intracranial hypertension and control patients. Outside of the standard care provided for these patients as part of their scheduled lumbar puncture, they will have measurements of their eye taken before and after their lumbar puncture.
Status | Not yet recruiting |
Enrollment | 66 |
Est. completion date | November 2025 |
Est. primary completion date | November 2025 |
Accepts healthy volunteers | |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility | Inclusion Criteria: - Males or female between the ages of 18 and 80 (inclusive). - Able to understand the study and give informed consent. - Willing, able and available to participate in all aspects of the study. - Able to undergo accurate tonography. - Diagnosis of Idiopathic intracranial hypertension (IIH) or suspected diagnosis of IIH as determined by a consultant subspecialist neurologist or neuro-ophthalmologist. Control group will only include: - Individuals requiring lumbar puncture as part of their standard care for reasons other than suspected raised intracranial pressure e.g. for cerebrospinal fluid (CSF) sampling to analyse oligoclonal bands or other conditions necessitating lumbar puncture for diagnostic/prognostic purposes. - Individuals suspected of having a raised intracranial pressure but, upon measurement of the opening pressure, are found to have an intracranial pressure within normal limits.* - In this study, where there are considered to be signs of raised intracranial pressure as judged by a consultant neuro ophthalmologist or neurologist, in combination with an opening CSF pressure 20cmH2O or greater, this will be taken as a raised intracranial pressure. Normal CSF pressure is taken as 19cmH2O or lower. In asymptomatic patients, pressures of up to 25cmH2O will be considered normal. Exclusion Criteria - Under 18 or over 80 years of age. - Diagnosis of ocular hypertension (ocular hypertension is defined as any individual with an intraocular pressure above 24mmHg measured on Goldman tonometry, irrespective of corneal thickness. This applies to intraocular pressure measured historically as well on the day of assessment). - Diagnosis of glaucoma of any subtype (glaucoma is defined on the basis of any glaucomatous optic nerve head appearance [including that defined on the basis of optic nerve head optical coherence tomography] or visual field defect, irrespective of intraocular pressure). - Diagnosis of any significant retinal, corneal or other ocular abnormality aside from optic nerve head oedema secondary to raised ICP. - Previous intraocular surgery or any surgery in which the conjunctiva has been breached e.g. optic nerve sheath fenestration or squint surgery. - Diagnosis of raised intracranial pressure secondary to space occupying lesions. - Any central nervous system or other systematic disorder that is likely to make lumbar puncture high risk or likely to render accurate recording of opening pressures unreliable. - Mental impairment conflicting with informed consent. - Patients who might not adequately understand written information given in English or verbal explanations in English will not be included as participants in the study must be able to understand English to complete some of the tests. - Participants will not be included if they are involved in research deemed by the investigators to impact the outcomes of this study. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Guy's and St Thomas' NHS Foundation Trust |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Measure the effect of LP induced change in intracranial pressure on outflow facility in patients with idiopathic intracranial hypertension compared to control patients | To investigate the effect of lumbar puncture induced changes in intracranial pressure on aqueous outflow facility in patients with known or suspected idiopathic intracranial hypertension, compared to control patients. | 18 Months | |
Secondary | Measure the difference in outflow facility between patients with idiopathic intracranial hypertension and control patients prior to lumbar puncture | To compare pre lumbar puncture aqueous outflow facility between patients with idiopathic intracranial hypertension and control patients. | 18 Months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT01863381 -
Comparison of Continuous Non-Invasive and Invasive Intracranial Pressure Measurement
|
N/A | |
Recruiting |
NCT06027567 -
The Effect of an Anti-obesity Drug, Semaglutide, as Treatment in New-onset Idiopathic Intracranial Hypertension (IIH) Compared to Standard Weight Management (Dietician) With Regards to Change in Weight and Intracranial Pressure
|
Phase 4 | |
Active, not recruiting |
NCT02896452 -
Astronaut Vision Issues in a Ground Analog Population: Polycystic Ovary Syndrome
|
||
Recruiting |
NCT06059703 -
Biomarkers in the Etiology of Idiopathic Intracranial Hypertension
|
N/A | |
Terminated |
NCT05347147 -
A Trial to Determine the Efficacy and Safety of Presendin in IIH
|
Phase 3 | |
Not yet recruiting |
NCT06361823 -
Exploratory Study on the Efficacy and Safety of Semaglutide for Idiopathic Intracranial Hypertension Treatment
|
Phase 3 | |
Active, not recruiting |
NCT02124486 -
An RCT of Bariatric Surgery vs a Community Weight Loss Programme for the Sustained Treatment of IIH
|
N/A | |
Recruiting |
NCT02143258 -
Stenting of Venous Sinus Stenosis for Medically Refractory Idiopathic Intracranial Hypertension
|
N/A | |
Enrolling by invitation |
NCT05308823 -
Outcome of Cerebral Venous Sinuses Stenting on Idiopathic Intracranial Hypertension
|
N/A | |
Not yet recruiting |
NCT05762367 -
MR Lymphatic Imaging in Idiopathic Intracranial Hypertention
|
N/A | |
Completed |
NCT03867461 -
The Effects of MAP and EtCO2 on Venous Sinus Pressures
|
N/A | |
Completed |
NCT03963336 -
Quantitative D-dimer Level and Anticoagulant Therapy in Idiopathic Intracranial Hypertension
|
Early Phase 1 | |
Completed |
NCT01003639 -
Idiopathic Intracranial Hypertension Treatment Trial
|
Phase 2/Phase 3 | |
Recruiting |
NCT03096743 -
Evaluating Raised Intracranial Pressure Using MR Elastography
|
N/A | |
Completed |
NCT04314128 -
Assessment of ICP in Idiopathic Intracranial Hypertension Using Transocular Ultrasound and Transcranial Doppler
|
N/A | |
Terminated |
NCT03501966 -
Surgical Idiopathic Intracranial Hypertension Treatment Trial
|
Phase 3 | |
Active, not recruiting |
NCT03556085 -
Venous Sinus Stenting With the River Stent in IIH
|
N/A | |
Completed |
NCT02017444 -
Safety and Effectiveness of 11b-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) to Treat Idiopathic Intracranial Hypertension.
|
Phase 2 |